DrugPatentWatch Database Preview
Details for Patent: 9,308,195
Which drugs does patent 9,308,195 protect, and when does it expire?
This patent has sixteen patent family members in sixteen countries.
Summary for Patent: 9,308,195
Title: | Non-aqueous taxane formulations and methods of using the same |
Abstract: | Non-aqueous, ethanol-free taxane formulations are provided. Formulations of embodiments of the invention include a taxane, an oil, a non-ionic surfactant, a non-aqueous solvent, and an organic acid component, wherein the organic acid component is soluble in the non-aqueous solvent and the amount by weight of non-ionic surfactant is equal to or greater than the amount by weight of non-aqueous solvent. Also provided are methods of using the formulations, as well as kits that include the formulations. Non-aqueous, ethanol-free docetaxel formulations are provided. Formulations of embodiments of the invention include docetaxel, an oil, a non-ionic surfactant, a non-aqueous solvent, and an organic acid which is soluble in the non-aqueous solvent and is substantially free of any conjugate base. Also provided are methods of using the formulations, as well as kits that include the formulations. |
Inventor(s): | Nabeta; Kiichiro (Tokyo, JP) |
Assignee: | Teikoku Pharma USA, Inc. (San Jose, CA) |
Application Number: | 14/564,384 |
Patent Claim Types: see list of patent claims | Formulation; Compound; Use; Device; |
Drugs Protected by US Patent 9,308,195
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eagle Pharms | DOCETAXEL | docetaxel | SOLUTION;IV (INFUSION) | 205934-001 | Dec 22, 2015 | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | ||||
Eagle Pharms | DOCETAXEL | docetaxel | SOLUTION;IV (INFUSION) | 205934-002 | Dec 22, 2015 | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | ||||
Eagle Pharms | DOCETAXEL | docetaxel | SOLUTION;IV (INFUSION) | 205934-003 | Dec 22, 2015 | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | ||||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
Non-Orange Book US Patents Family Members for Patent 9,308,195
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
Patent No. | Title | Estimated Patent Expiration |
---|---|---|
8,940,786 | Non-aqueous taxane nanodispersion formulations and methods of using the same | ➤ Try a Free Trial |
9,763,880 | Non-aqueous taxane formulations and methods of using the same | ➤ Try a Free Trial |
Patent No. | Title | Estimated Patent Expiration |
International Patents Family Members for US Patent 9,308,195
Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 092759 | ➤ Try a Free Trial | |||
Australia | 2013327563 | ➤ Try a Free Trial | |||
Canada | 2885930 | ➤ Try a Free Trial | |||
China | 104822262 | ➤ Try a Free Trial | |||
Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |